🔴 Omnicell is trading 5.04% down today as post-earnings selloff continues on cautious guidance

Omnicell is trading at $35.24 (-5.04%) as the stock extends losses following a sharp post-earnings selloff on July 30.

• While the company reported 7% revenue growth and non-GAAP EPS of $0.94, investor sentiment remains weighed down by cautious guidance and the one-time nature of a tariff refund that boosted recent margins.
• The stock's decline follows a 10.36% drop in the previous session, further exacerbated by broader sector weakness as the Health Care Select Sector SPDR Fund (XLV) trades down 1.28%.